Page last updated: 2024-09-05

erlotinib hydrochloride and Mental Disorders

erlotinib hydrochloride has been researched along with Mental Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gwak, HS; Han, JY; Joo, J; Kim, HT; Kim, S; Lee, JS; Lee, SH; Shin, SH; Yoo, H1
García, N; Mezquita-Pérez, L; Pian, H1

Other Studies

2 other study(ies) available for erlotinib hydrochloride and Mental Disorders

ArticleYear
Analysis of treatment outcomes of intraventricular chemotherapy in 105 patients for leptomeningeal carcinomatosis from non-small-cell lung cancer.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2013, Volume: 8, Issue:5

    Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cranial Nerve Diseases; Cytarabine; Erlotinib Hydrochloride; Female; Gefitinib; Headache; Humans; Hydrocortisone; Infusions, Intraventricular; Intracranial Pressure; Karnofsky Performance Status; Lung Neoplasms; Male; Meningeal Carcinomatosis; Mental Disorders; Methotrexate; Middle Aged; Nausea; Palliative Care; Protein Kinase Inhibitors; Quinazolines; Retrospective Studies; Vomiting

2013
Unusual progressive neurological syndrome in epidermal growth factor receptor-mutated lung adenocarcinoma, diagnosed at autopsy as invasive meningeal carcinomatosis.
    Archivos de bronconeumologia, 2016, Volume: 52, Issue:11

    Topics: Adenocarcinoma; Coma; Dysarthria; ErbB Receptors; Erlotinib Hydrochloride; Fatal Outcome; Female; Genes, erbB-1; Humans; Lung Neoplasms; Meningeal Carcinomatosis; Mental Disorders; Middle Aged; Neoplasm Proteins; Protein Kinase Inhibitors; Sequence Deletion

2016